Search Results
Aug 06, 2026, 16:03 ET BioLife Solutions Reports Second Quarter 2026 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, announces
More news about: BioLife Solutions, Inc.
Jul 29, 2026, 13:42 ET $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWD
BLFS) related to its sale to Repligen Corporation. Under the terms of the proposed transaction, BioLife shareholders are expected to receive $11.25
More news about: Monteverde & Associates PC
Jul 28, 2026, 10:44 ET Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-ng-blfs-nrim-obtaining-fair-deals-for-their-shareholders-302836460.htmlSOURCE
More news about: Halper Sadeh LLP
Jul 23, 2026, 12:10 ET Are UTZ, BLFS, FNWD Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-utz-blfs-fnwd-obtaining-fair-deals-for-their-shareholders-302833369.htmlSOURCE
More news about: Halper Sadeh LLP
Jul 22, 2026, 14:04 ET $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS)
BLFS) related to its sale to Repligen Corporation. Under the terms of the proposed transaction, BioLife shareholders are expected to receive $11.25
More news about: Monteverde & Associates PC
Jul 22, 2026, 11:34 ET Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, July 22, 2026 /PRNewswire/ -- Ademi LLP is investigating BioLife (NASDAQ: BLFS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Repligen.
More news about: Ademi LLP
May 07, 2026, 16:03 ET BioLife Solutions Reports First Quarter 2026 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market,
More news about: BioLife Solutions, Inc.
Apr 23, 2026, 16:03 ET BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the 2026 first
More news about: BioLife Solutions, Inc.
Apr 21, 2026, 16:15 ET BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase
BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced it has received
More news about: BioLife Solutions, Inc.
Feb 26, 2026, 16:03 ET BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, today
More news about: BioLife Solutions, Inc.
Feb 17, 2026, 08:04 ET BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the 2025 fourth
More news about: BioLife Solutions, Inc.
Feb 12, 2026, 08:03 ET BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a
More news about: BioLife Solutions, Inc.
Jan 12, 2026, 08:03 ET BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market,
More news about: BioLife Solutions, Inc.
Nov 20, 2025, 08:04 ET BioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation Excellence
BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today announced the opening
More news about: BioLife Solutions, Inc.
Nov 17, 2025, 07:15 ET BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025
BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today announced that management
More news about: BioLife Solutions, Inc.
Nov 06, 2025, 16:03 ET BioLife Solutions Reports Third Quarter 2025 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market,
More news about: BioLife Solutions, Inc.
Oct 23, 2025, 16:03 ET BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's
More news about: BioLife Solutions, Inc.
Oct 07, 2025, 08:04 ET BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools for the cell and gene therapy ("CGT") market, announces the
More news about: BioLife Solutions, Inc.